Cocrystal Pharma

(NASDAQ) COCP

Current Price$1.19

Market Cap$16.54M

Since IPO (2014)-100%

5 Year-91%

1 Year-17%

1 Month-20%

Cocrystal Pharma Financials at a Glance

Market Cap

$16.54M

Revenue (TTM)

$0.00

Net Income (TTM)

$8.83M

EPS (TTM)

$-0.79

P/E Ratio

-1.52

Dividend

$0.00

Beta (Volatility)

0.69 (Low)

Dividend

$0.00

Beta (Volatility)

0.69 (Low)

Price

$1.19

Volume

5,592

Open

$1.24

Price

$1.19

Volume

5,592

Open

$1.24

Previous Close

$1.19

Daily Range

$1.19 - $1.27

52-Week Range

$0.86 - $2.67

Dividend

$0.00

Beta (Volatility)

0.69 (Low)

Price

$1.19

Volume

5,592

Open

$1.24

Previous Close

$1.19

Daily Range

$1.19 - $1.27

52-Week Range

$0.86 - $2.67

COCP News

Cocrystal Pharma Narrows Loss in Q2

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cocrystal Pharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Sam Lee, PhD; James Joseph Martin, MBA, CPA

Website

www.cocrystalpharma.com

Headquarters

Bothell, WA 98011, US

COCP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-111%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-65.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.54M

Shares Outstanding

13.79M

Volume

5.59K

Avg. Volume

2.40M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$9.02M

EBITDA

$8.64M

Operating Cash Flow

$8.19M

Capital Expenditure

$12.00K

Free Cash Flow

$8.20M

Cash & ST Invst.

$7.03M

Total Debt

$1.50M

Cocrystal Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$16.54M

N/A

Market Cap/Employee

$1.50M

N/A

Employees

N/A

Net Income

$2.30M

+0.1%

EBITDA

$2.36M

-1.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$3.26M

-37.1%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$1.08M

-24.1%

Short Term Debt

$343.00K

+11.0%

Return on Assets

-1.19%

N/A

Return on Invested Capital

-1.74%

N/A

Free Cash Flow

$2.34M

+20.4%

Operating Cash Flow

$2.34M

+20.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TRAWTraws Pharma, Inc.

TRAWTraws Pharma, Inc.$1.88+15.34%

MRKRMarker Therapeutics, Inc.

MRKRMarker Therapeutics, Inc.$1.42-2.74%

BOLTBolt Biotherapeutics, Inc.

BOLTBolt Biotherapeutics, Inc.$4.78-4.40%

CINGCingulate Inc.

CINGCingulate Inc.$4.57+4.10%

IMRNImmuron Limited

IMRNImmuron Limited$1.00-9.46%

IMNNImunon, Inc.

IMNNImunon, Inc.$2.49-2.35%

EVGNEvogene Ltd.

EVGNEvogene Ltd.$0.73-1.49%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

FIGFigma

FIGFigma$22.92+0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

PIIIP3 Health Partners

PIIIP3 Health Partners$11.29+1.80%

Questions About COCP

What is the current price of Cocrystal Pharma?

Cocrystal Pharma is trading at $1.19 per share.

What is the 52-week range for Cocrystal Pharma?

Over the past 52 weeks, Cocrystal Pharma has traded between $0.86 and $2.67.

How much debt does Cocrystal Pharma have?

As of the most recent reporting period, Cocrystal Pharma reported total debt of $1.50M.

How much cash does Cocrystal Pharma have on hand?

Cocrystal Pharma reported $7.10M in cash and cash equivalents in its most recent financial results.

What is Cocrystal Pharma’s dividend yield?

Cocrystal Pharma does not currently have a dividend yield.

Cocrystal Pharma

Cocrystal Pharma Financials at a Glance

COCP News

Cocrystal Pharma Narrows Loss in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cocrystal Pharma

COCP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cocrystal Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About COCP

What is the current price of Cocrystal Pharma?

What is the 52-week range for Cocrystal Pharma?

How much debt does Cocrystal Pharma have?

How much cash does Cocrystal Pharma have on hand?

What is Cocrystal Pharma’s dividend yield?

Premium Investing Services